0000899243-23-007798.txt : 20230309 0000899243-23-007798.hdr.sgml : 20230309 20230309213223 ACCESSION NUMBER: 0000899243-23-007798 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180629 FILED AS OF DATE: 20230309 DATE AS OF CHANGE: 20230309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SASSINE ANDY CENTRAL INDEX KEY: 0001515322 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09341 FILM NUMBER: 23721453 MAIL ADDRESS: STREET 1: 82 DEVONSHIRE STREET CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICAD INC CENTRAL INDEX KEY: 0000749660 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 020377419 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 BUSINESS PHONE: 603-882-5200 MAIL ADDRESS: STREET 1: 98 SPIT BROOK ROAD, SUITE 100 CITY: NASHUA STATE: NH ZIP: 03062 FORMER COMPANY: FORMER CONFORMED NAME: HOWTEK INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-29 0 0000749660 ICAD INC ICAD 0001515322 SASSINE ANDY 98 SPIT BROOK ROAD, SUITE 100 NASHUA NH 03062 1 0 0 0 Director Stock Option (right to buy) 3.05 2018-06-29 4 D 0 6219 D 2023-06-29 Common Stock 6219 0 D Director Stock Option (right to buy) 3.05 2023-03-07 4 A 0 6219 A 2028-06-29 Common Stock 6219 6219 D Director Stock Option (right to buy) 2.91 2018-09-28 4 D 0 6517 D 2023-09-28 Common Stock 6517 0 D Director Stock Option (right to buy) 2.91 2023-03-07 4 A 0 6517 A 2028-09-28 Common Stock 6517 6517 D Director Stock Option (right to buy) 3.70 2018-12-31 4 D 0 9321 D 2023-12-31 Common Stock 9321 0 D Director Stock Option (right to buy) 3.70 2023-03-07 4 A 0 9321 A 2028-12-31 Common Stock 9321 9321 D The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 29, 2018 and is fully vested as of the date hereof. The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on September 28, 2018 and is fully vested as of the date hereof. The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 31, 2018 and is fully vested as of the date hereof. On March 7, 2023, the Board of Directors of the Issuer agreed to a modification of the exercise period for certain outstanding stock options granted to the Director in 2018 that would otherwise expire in November 2023 such that they now have an aggregate exercise period of ten years. No other modification was made to the option. /s/ Andy Sassine 2023-03-09